The safety profile of topical calcipotriol in humans during pregnancy has not been established. Orally administered treatment to animals during pregnancy showed levels of toxicity. Calcipotriol should not be used in pregnancy unless absolutely necessary.
There is no data to state whether calcipotriol is excreted into breast milk. Caution should be used when prescribing Dovonex Ointment to breast feeding mothers. If prescribed, the mother should be advised not to apply the ointment to the breasts.
A full list of contraindications and cautions can be accessed by clicking here for the summary of product characteristics.